Simultaneous Determination of Imatinib, Dasatinib, and Nilotinib by Liquid Chromatography-Tandem Mass Spectrometry and Its Application to Therapeutic Drug Monitoring.
Ther Drug Monit
; 39(3): 252-262, 2017 06.
Article
in En
| MEDLINE
| ID: mdl-28490048
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrimidines
/
Protein Kinase Inhibitors
/
Imatinib Mesylate
/
Dasatinib
Type of study:
Guideline
Limits:
Humans
Language:
En
Journal:
Ther Drug Monit
Year:
2017
Document type:
Article